title: Castleman disease and adenocarcinoma.
authors.forename: A
authors.initials: A
authors.lastname: Megalakaki
authors.forename: I
authors.initials: I
authors.lastname: Evmorfiadis
authors.forename: M
authors.initials: M
authors.lastname: Stamouli
authors.forename: N
authors.initials: N
authors.lastname: Zakopoulou
authors.forename: I
authors.initials: I
authors.lastname: Iacovidou
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D005871:Castleman Disease / Q000188:drug therapy / Q000473:pathology*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000473:pathology* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone